This review initiates by outlining the clinical relevance of IA, underlining the pressing need to
comprehend its foundational elements. We delve into the assorted risk factors tied to IA …

Intracranial aneurysms (IAs), as a common cerebrovascular disease, claims a worldwide
morbidity rate of 3.2%. Inflammation, pivotal in the pathogenesis of IAs, influences their …

OBJECTIVE Calcium channel blockers (CCBs) are antihypertensive agents with potential
vascular protection effects. This study investigated whether CCB usage was associated with …

Aims Hypertension is a risk factor for intracranial aneurysm rupture. We analysed whether
the intake of drugs from specific classes of anti-hypertensive medications affects …

The rising burden of cardiovascular disease in South Africa gives impetus to managerial
changes, particularly to the available foods in the market. Since there are many …

Background Predicting rupture risk is important for aneurysm management. This research
aimed to develop and validate a nomogram model to forecast the rupture risk of posterior …

Background Hypertension is widely acknowledged as a significant contributory factor to the
heightened risk of intracranial aneurysm rupture. Nevertheless, the impact of hypertension …

Management of intracranial aneurysms (IAs) is determined by patient age, risk of rupture,
and comorbid conditions. While endovascular and microsurgical interventions offer solutions …

Introduction: Observational studies suggest that different classes of antihypertensive drugs
may have different effects on the occurrence of intracranial aneurysms (IA) and …

Objective Several studies have explored the relationship between intracranial aneurysms
and psychiatric disorders; nevertheless, the causal connection remains ambiguous. This …